Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Staar Surgical Co.

Submit EVO family of myopia lens trial data to the FDA for marketing approval

Delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
25 Feb 2021
Due
30 Apr 2021
Delivered
April 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Our plan remains to submit the data to the FDA for marketing approval in late April.”

What we found

Evidence strength A What the grades mean

Multiple later filings state the FDA received EVO clinical data in late April 2021, matching the stated late-April submission deadline.

  • A
    Staar Surgical Co. 10-Q filed 2021-05-05 Regulatory filing · published 5 May 2021 · retrieved 26 Oct 2026 · kept permanently by the SEC
    “In late April, the FDA received our clinical data for our EVO family of myopia lenses with the goal of bringing EVO to the U.S. market later this year.” ✓ confirmed on the page
  • A
    Staar Surgical Co. 8-K filed 2021-05-27 Regulatory filing · published 27 May 2021 · retrieved 26 Oct 2026 · kept permanently by the SEC
    “Submitted to FDA for marketing approval in late April 2021” ✓ confirmed on the page
  • A
    Staar Surgical Co. 10-K filed 2022-02-23 Regulatory filing · published 23 Feb 2022 · retrieved 26 Oct 2026 · kept permanently by the SEC
    “In April 2021, we submitted clinical data to the FDA to support a marketing approval for our EVO family of myopia lenses.” ✓ confirmed on the page

Checked 26 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Submit
Deliverable
FDA marketing approval submission for EVO myopia lenses
Where
United States
Language
Expected (“expects”, “plans”)
In the company’s control
High
Specificity
High
Depends on
Regulatory

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Staar Surgical Co.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-STAA-024629 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.